PMID- 34087019 OWN - NLM STAT- MEDLINE DCOM- 20220107 LR - 20220531 IS - 1399-3038 (Electronic) IS - 0905-6157 (Linking) VI - 32 IP - 8 DP - 2021 Nov TI - Metabolomics reveals microbial-derived metabolites associated with immunoglobulin E responses in filaggrin-related atopic dermatitis. PG - 1709-1717 LID - 10.1111/pai.13570 [doi] AB - BACKGROUND: Filaggrin (FLG) gene mutation and immunoglobulin E (IgE)-mediated sensitization are the most important predictors of atopic dermatitis (AD). However, a metabolomics-based approach to address the metabolic impact of FLG mutations on allergic IgE responses for AD is still lacking. We, though, determine the relationships of metabolic profiles in AD with FLG mutations and allergic responses. METHODS: Eighty-one children with adolescent AD (n = 58) and healthy controls (n = 23) were prospectively enrolled. Mutations in the filaggrin gene were identified using whole-exome sequencing, and plasma metabolic profiles were determined using (1) H-nuclear magnetic resonance (NMR) spectroscopy. Integrative analyses of their associations related to total serum IgE levels were performed, and further metabolic functional pathways for AD were also assessed. RESULTS: Metabolites contributed to the separation between AD and controls were identified using the supervised partial least squares discriminant analysis (Q(2) /R(2) = 0.90, P(permutation) <0.001). Nitrogen and amino acid metabolisms for energy production, and microbe-related methane and propanoate metabolisms were significantly associated with AD compared with healthy controls (FDR-adjusted p < .05). Five of fifteen metabolites related to FLG mutations were positively correlated with total serum IgE levels. Among them, dimethylamine and isopropanol were strongly associated with methane metabolism and propanoate metabolism, respectively, in AD with FLG mutations (FDR-adjusted p < .01). CONCLUSION: A strong correlation of microbial-derived metabolites, dimethylamine and isopropanol, with FLG mutations and IgE allergic reactions provides the influence of host genetics on the microbiome to regulate susceptibility to allergic responses in the pathogenesis of AD. CI - (c) 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. FAU - Chiu, Chih-Yung AU - Chiu CY AUID- ORCID: 0000-0002-6454-968X AD - Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan. AD - Clinical Metabolomics Core Laboratory, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan. FAU - Lin, Gigin AU - Lin G AD - Clinical Metabolomics Core Laboratory, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan. AD - Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan. FAU - Wang, Chia-Jung AU - Wang CJ AD - Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan. FAU - Hung, Shuen-Iu AU - Hung SI AD - Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan. FAU - Chung, Wen-Hung AU - Chung WH AD - Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Taiwan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210705 PL - England TA - Pediatr Allergy Immunol JT - Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology JID - 9106718 RN - 0 (FLG protein, human) RN - 0 (Filaggrin Proteins) RN - 0 (Intermediate Filament Proteins) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Adolescent MH - Case-Control Studies MH - Child MH - *Dermatitis, Atopic/genetics MH - *Filaggrin Proteins MH - Humans MH - Immunoglobulin E MH - Intermediate Filament Proteins/genetics MH - Metabolomics MH - Mutation OTO - NOTNLM OT - IgE OT - atopic dermatitis OT - filaggrin mutations OT - microbial-derived metabolites EDAT- 2021/06/05 06:00 MHDA- 2022/01/08 06:00 CRDT- 2021/06/04 17:39 PHST- 2021/05/23 00:00 [revised] PHST- 2021/01/06 00:00 [received] PHST- 2021/05/31 00:00 [accepted] PHST- 2021/06/05 06:00 [pubmed] PHST- 2022/01/08 06:00 [medline] PHST- 2021/06/04 17:39 [entrez] AID - 10.1111/pai.13570 [doi] PST - ppublish SO - Pediatr Allergy Immunol. 2021 Nov;32(8):1709-1717. doi: 10.1111/pai.13570. Epub 2021 Jul 5.